Literature DB >> 15710586

Gammadelta and alphabeta T-cell acute lymphoblastic leukemia: comparison of their clinical and immunophenotypic features.

Daniel Mazza Matos, Edgar Gil Rizzatti, Margareth Fernandes, Valeria Buccheri, Roberto Passetto Falcão.   

Abstract

Gammadelta-T-cell acute lymphoblastic leukemia (ALL) is a rare variant of ALL. The comparison of some clinical and laboratory features in children and adults with gammadelta-T-ALL or alphabeta-ALL showed that in gammadelta-T-ALL the CD45RAEth/CD45RO+ phenotype was predominant, the hemoglobin concentration was lower in children and the presence of splenomegaly and the white cell counts was higher in adults.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15710586

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  10 in total

1.  Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor.

Authors:  Ching-Hon Pui; Deqing Pei; Cheng Cheng; Suzanne L Tomchuck; Scarlett N Evans; Hiroto Inaba; Sima Jeha; Susana C Raimondi; John K Choi; Paul G Thomas; Mari Hashitate Dallas
Journal:  Oncoimmunology       Date:  2019-05-17       Impact factor: 8.110

2.  A novel case of γδ T cell leukemia with recurrent genetic abnormalities accompanied by agranulocytosis.

Authors:  Satoshi Ichikawa; Tohru Fujiwara; Kei Saito; Noriko Fukuhara; Hisayuki Yokoyama; Shunsuke Hatta; Koichi Onodera; Yasushi Onishi; Fumiyoshi Fujishima; Ryo Ichinohasama; Hideo Harigae
Journal:  Ann Hematol       Date:  2020-08-31       Impact factor: 3.673

Review 3.  γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Authors:  Bruno Silva-Santos; Sofia Mensurado; Seth B Coffelt
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

4.  Multifaceted CK2 in malignant and healthy T cells.

Authors:  Sérgio T Ribeiro; João T Barata; Bruno Silva-Santos
Journal:  Oncotarget       Date:  2017-10-09

5.  Casein kinase 2 controls the survival of normal thymic and leukemic γδ T cells via promotion of AKT signaling.

Authors:  S T Ribeiro; M Tesio; J C Ribot; E Macintyre; J T Barata; B Silva-Santos
Journal:  Leukemia       Date:  2016-11-30       Impact factor: 11.528

6.  γδ T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Discussion of Two Pediatric Cases and Its Distinction from Other Mature γδ T-Cell Malignancies.

Authors:  Eric X Wei; Vasiliki Leventaki; John K Choi; Susana C Raimondi; Elizabeth M Azzato; Sheila A Shurtleff; Menchu G Ong; Diana M Veillon; James D Cotelingam; Rodney E Shackelford
Journal:  Case Rep Hematol       Date:  2017-09-24

7.  Gamma-Delta T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Immunophenotype of Three Adult Cases.

Authors:  Wei Wang; Yan Li; Min Ou-Yang; Meixiang Zhang; Linjun Zhao; Jianxin Liu; Yao Zhang; Wenqing Hu; Bin Jiang
Journal:  J Hematol (Brossard)       Date:  2019-09-30

8.  A Challenging Case of Gamma Delta T-Cell Lymphoma with Precursor T-Cells and Marked Eosinophilia: A Case Report.

Authors:  Samah Kohla; Feryal Ibrahim; Ilham Bilal; Einas Al Kuwari; Ahmad Al-Sabbagh
Journal:  Case Rep Oncol       Date:  2020-12-18

9.  Chimeric antigen receptor T cells for gamma-delta T cell malignancies.

Authors:  P A Wawrzyniecka; L Ibrahim; G Gritti; M A Pule; P M Maciocia
Journal:  Leukemia       Date:  2021-08-13       Impact factor: 11.528

Review 10.  The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.

Authors:  Susann Schönefeldt; Tamara Wais; Marco Herling; Satu Mustjoki; Vasileios Bekiaris; Richard Moriggl; Heidi A Neubauer
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.